The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

SNY's SAR446597, a one-time intravitreal gene therapy, secures FDA fast track tag for geographic atrophy due to age-related ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

For the third time in four years, CNBC ranks North Carolina as Top State for Business. To learn more, click here. Hosted by the Central Carolina Community College's (CCCC) Biotechnology Department, ...

The motor neuron disease treatment market is witnessing substantial growth, primarily fueled by the rising incidence of conditions like Amyotrophic L ...